Intravenous infusion of salbutamol in the management of premature labour.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage*; D002082:Butylamines / Q000008:administration & dosage; D002584:Cervix Uteri / Q000502:physiology; D000431:Ethanol / Q000627:therapeutic use; D004983:Ethanolamines / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D005321:Extraembryonic Membranes; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007275:Injections, Intravenous; D009119:Muscle Contraction / Q000187:drug effects; D007752:Obstetric Labor, Premature / Q000188:drug therapy*; D010627:Phenethylamines / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D011247:Pregnancy; D011312:Pressure; D011674:Pulse / Q000187:drug effects; D012127:Respiratory Distress Syndrome, Newborn / Q000517:prevention & control; D013610:Tachycardia / Q000139:chemically induced; D014599:Uterus / Q000187:drug effects
D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D002082:Butylamines; D004983:Ethanolamines; D010627:Phenethylamines; D000431:Ethanol